The Japanese Breast Cancer Society clinical practice guideline for surgical treatment of breast cancer, 2015 edition

被引:18
|
作者
Jinno, Hiromitsu [1 ]
Inokuchi, Masafumi [2 ]
Ito, Toshikazu [3 ]
Kitamura, Kaoru [4 ]
Kutomi, Goro [5 ]
Sakai, Takehiko [6 ]
Kijima, Yuko [7 ]
Wada, Noriaki [8 ]
Ito, Yoshinori [9 ]
Mukai, Hirofumi [8 ]
机构
[1] Teikyo Univ, Sch Med, Dept Surg, 2-11-1 Kaga, Tokyo, Tokyo 1738606, Japan
[2] Kanazawa Univ Hosp, Dept Breast Oncol, Kanazawa, Ishikawa, Japan
[3] Rinku Gen Med Ctr, Dept Surg, Osaka, Japan
[4] Nagumo Clin Fukuoka, Dept Breast Surg, Fukuoka, Japan
[5] Sapporo Med Univ, Hosp Hokkaido, Dept Surg Surg Oncol & Sci, Sapporo, Hokkaido, Japan
[6] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Oncol Ctr, Tokyo, Japan
[7] Kagoshima Univ, Sch Med, Dept Digest Surg Breast & Thyroid Surg, Kagoshima 890, Japan
[8] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Gen & Breast Surg, Chiba, Japan
[9] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Breast Med Oncol, Tokyo, Japan
关键词
LYMPH-NODE BIOPSY; CARCINOMA IN-SITU; 20-YEAR FOLLOW-UP; NEOADJUVANT CHEMOTHERAPY; AXILLARY DISSECTION; CONSERVING SURGERY; RADICAL-MASTECTOMY; PROGNOSTIC-FACTORS; LOCAL RECURRENCE; BRAIN METASTASES;
D O I
10.1007/s12282-016-0671-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:367 / 377
页数:11
相关论文
共 50 条
  • [41] The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment
    Yamamoto, Yutaka
    Yamauchi, Chikako
    Toyama, Tatsuya
    Nagai, Shigenori
    Sakai, Takehiko
    Kutomi, Goro
    Yoshimura, Michio
    Kawai, Masaaki
    Ohtani, Shoichiro
    Kubota, Kazunori
    Nakashima, Kazutaka
    Honma, Naoko
    Yoshida, Masayuki
    Tokunaga, Eriko
    Taira, Naruto
    Iwata, Hiroji
    Saji, Shigehira
    BREAST CANCER, 2024, 31 (03) : 340 - 346
  • [42] The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment
    Yutaka Yamamoto
    Chikako Yamauchi
    Tatsuya Toyama
    Shigenori Nagai
    Takehiko Sakai
    Goro Kutomi
    Michio Yoshimura
    Masaaki Kawai
    Shoichiro Ohtani
    Kazunori Kubota
    Kazutaka Nakashima
    Naoko Honma
    Masayuki Yoshida
    Eriko Tokunaga
    Naruto Taira
    Hiroji Iwata
    Shigehira Saji
    Breast Cancer, 2024, 31 : 340 - 346
  • [43] The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition
    Kubota, Kazunori
    Nakashima, Kazutaka
    Nakashima, Kazuaki
    Kataoka, Masako
    Inoue, Kenich
    Goto, Mariko
    Kanbayashi, Chizuko
    Hirokaga, Koichi
    Yamaguchi, Ken
    Suzuki, Akihiko
    BREAST CANCER, 2024, 31 (02) : 157 - 164
  • [44] The Japanese breast cancer society clinical practice guidelines for pathological diagnosis of breast cancer, 2022 edition
    Honma, Naoko
    Yoshida, Masayuki
    Kinowaki, Keiichi
    Horii, Rie
    Katsurada, Yuka
    Murata, Yuya
    Shimizu, Ai
    Tanabe, Yuko
    Yamauchi, Chikako
    Yamamoto, Yutaka
    Iwata, Hiroji
    Saji, Shigehira
    BREAST CANCER, 2024, 31 (01) : 8 - 15
  • [45] The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 Edition
    Uematsu, Takayoshi
    Nakashima, Kazutaka
    Kikuchi, Mari
    Kubota, Kazunori
    Suzuki, Akihiko
    Nakano, Shogo
    Hirokaga, Kouichi
    Yamaguchi, Ken
    Saji, Shigehira
    Iwata, Hiroji
    BREAST CANCER, 2020, 27 (01) : 17 - 24
  • [46] The Japanese breast cancer society clinical practice guidelines for pathological diagnosis of breast cancer, 2022 edition
    Naoko Honma
    Masayuki Yoshida
    Keiichi Kinowaki
    Rie Horii
    Yuka Katsurada
    Yuya Murata
    Ai Shimizu
    Yuko Tanabe
    Chikako Yamauchi
    Yutaka Yamamoto
    Hiroji Iwata
    Shigehira Saji
    Breast Cancer, 2024, 31 : 8 - 15
  • [47] The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2022 edition
    Kawai, Masaaki
    Ohtani, Shoichiro
    Iwasaki, Motoki
    Yamamoto, Seiichiro
    Takamatsu, Kiyoshi
    Okamura, Hitoshi
    Arai, Masami
    Nomura, Tsunehisa
    Ozaki, Shinji
    Shibata, Ken-ichi
    Akabane, Ayaka
    Motoi, Fuyuhiko
    Yamauchi, Chikako
    Yamamoto, Yutaka
    Iwata, Hiroji
    Saji, Shigehira
    BREAST CANCER, 2024, 31 (02) : 166 - 178
  • [48] The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2022 edition
    Masaaki Kawai
    Shoichiro Ohtani
    Motoki Iwasaki
    Seiichiro Yamamoto
    Kiyoshi Takamatsu
    Hitoshi Okamura
    Masami Arai
    Tsunehisa Nomura
    Shinji Ozaki
    Ken-ichi Shibata
    Ayaka Akabane
    Fuyuhiko Motoi
    Chikako Yamauchi
    Yutaka Yamamoto
    Hiroji Iwata
    Shigehira Saji
    Breast Cancer, 2024, 31 : 166 - 178
  • [49] The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 Edition
    Takayoshi Uematsu
    Kazutaka Nakashima
    Mari Kikuchi
    Kazunori Kubota
    Akihiko Suzuki
    Shogo Nakano
    Kouichi Hirokaga
    Ken Yamaguchi
    Shigehira Saji
    Hiroji Iwata
    Breast Cancer, 2020, 27 : 17 - 24
  • [50] Alcohol consumption and breast cancer prognosis after breast cancer diagnosis: a systematic review and meta‑analysis of the Japanese Breast Cancer Society Clinical Practice Guideline, 2022 edition
    Tsunehisa Nomura
    Masaaki Kawai
    Yuna Fukuma
    Yoshikazu Koike
    Shinji Ozaki
    Motoki Iwasaki
    Seiichiro Yamamoto
    Kiyoshi Takamatsu
    Hitoshi Okamura
    Masami Arai
    Shoichiro Ootani
    Hiroji Iwata
    Shigehira Saji
    Breast Cancer, 2023, 30 : 519 - 530